Strengthening Partnerships: Mochida Pharmaceuticals Visits Shannon HQ to discuss 2025 Collaborative Projects
The Mochida Pharmaceuticals leadership, quality and regulatory teams visited our headquarters in Shannon, Ireland this month, to discuss collaborative development projects for 2025 and beyond.
We are pleased to share that the future is bright, with projects planned for trauma, tendon & ligament, as well as cavernous nerve.
Pictured below is our Managing Partner, Paul Burke and Chief Science Officer, Gerard Insley presenting Hitoshi Mizuno, Head of Biomaterials business Division at Mochida Pharmaceuticals Ltd, with a plaque to mark the successful launch of ReFeel Nerve Repair Solution ‘Le Cheile’.
#mochidapharamceuticals #ReFeelnerverepairsolution #acceleratingmedicalinnovation #partners
